World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 77 1810 1654 890 801 361 23878

Michail S. Lionakis publications per year

The chart shows the history of publications by Michail S. Lionakis between 1997 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Michail S. Lionakis published across 30 years, from 1997 to 2026, averaging 15.3 papers a year. Output peaked at 69 publications in 2020. 31 of the 458 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1997 to 2026. Vertical axis: number of publications, 0 to 69. Peak 69 publications in 2020. 1997: 2 publications 1998: 0 publications 1999: 0 publications 2000: 0 publications 2001: 0 publications 2002: 0 publications 2003: 4 publications 2004: 5 publications 2005: 9 publications 2006: 2 publications 2007: 1 publication 2008: 2 publications 2009: 0 publications 2010: 1 publication 2011: 5 publications 2012: 7 publications 2013: 6 publications 2014: 5 publications 2015: 13 publications 2016: 16 publications 2017: 25 publications 2018: 34 publications 2019: 31 publications 2020: 69 publications 2021: 50 publications 2022: 41 publications 2023: 65 publications 2024: 34 publications 2025: 30 publications 2026: 1 publication
1997 2026

458 publications in total across all disciplines

View publications per year as a table
Michail S. Lionakis: publications per year, 1997 to 2026
Year Publications
1997 2
1998 0
1999 0
2000 0
2001 0
2002 0
2003 4
2004 5
2005 9
2006 2
2007 1
2008 2
2009 0
2010 1
2011 5
2012 7
2013 6
2014 5
2015 13
2016 16
2017 25
2018 34
2019 31
2020 69
2021 50
2022 41
2023 65
2024 34
2025 30
2026 1
Total 458
Download as CSV

Michail S. Lionakis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michail S. Lionakis sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 352–361 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 361 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69 361
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Michail S. Lionakis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michail S. Lionakis sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 76–77 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 77 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163 77
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Michail S. Lionakis is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research focuses primarily on Medicine, with significant contributions in Immunology and Microbiology. Within these fields, they have specialized in Immunology, Infectious Diseases, Epidemiology, Genetics, and Endocrinology, Diabetes and Metabolism.

The scientist's main research topics include antifungal resistance and susceptibility, fungal infections and studies, immunodeficiency and autoimmune disorders, adrenal hormones and disorders, SARS-CoV-2 and COVID-19 research, diabetes and associated disorders, and clinical research related to COVID-19.

Some of the recent papers authored or co-authored by Michail S. Lionakis include:

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19, 2020, Science
  • Inhibition of Bruton tyrosine kinase in patients with severe COVID-19, 2020, Science Immunology
  • Pathogenesis and virulence of Candida albicans, 2021, Virulence
  • An immune-based biomarker signature is associated with mortality in COVID-19 patients, 2020, JCI Insight
  • Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1, 2021, The Journal of Experimental Medicine

Frequent co-authors collaborating with Michail S. Lionakis include Elise M. N. Ferré, Steven M. Holland, Luigi D. Notarangelo, Jigar V. Desai, and Monica M. Schmitt.

Publications appear regularly in venues such as Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature, bioRxiv (Cold Spring Harbor Laboratory), The Journal of Immunology, Journal of Allergy and Clinical Immunology, and Open Forum Infectious Diseases.

Best Publications

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis

  • Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases

    Dimitrios P Kontoyiannis;Michail S. Lionakis;Russell E. Lewis;Russell E. Lewis;Georgios Chamilos

  • Glucocorticoids and invasive fungal infections.

    Michail S Lionakis;Dimitrios P Kontoyiannis

  • Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

    Michail S. Lionakis;Kieron Dunleavy;Mark Roschewski;Brigitte C. Widemann

  • Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.

    Georgios Chamilos;Edith M. Marom;Russell E. Lewis;Michail S. Lionakis

  • Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

    Unknown

  • Isolation of mouse neutrophils.

    Muthulekha Swamydas;Yi Luo;Martin E. Dorf;Michail S. Lionakis

  • Inhibition of Bruton tyrosine kinase in patients with severe COVID-19.

    Mark Roschewski;Michail S. Lionakis;Jeff P. Sharman;Joseph Roswarski

  • Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases

    William J. Steinbach;Daniel K. Benjamin;Dimitrios P Kontoyiannis;John R. Perfect

  • An immune-based biomarker signature is associated with mortality in COVID-19 patients.

    Michael S. Abers;Ottavia M. Delmonte;Emily E. Ricotta;Jonathan Fintzi

  • Organ-specific innate immune responses in a mouse model of invasive candidiasis.

    Michail S. Lionakis;Jean K. Lim;Chyi-Chia Richard Lee;Philip M. Murphy

  • Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

    Elise M.N. Ferre;Stacey R. Rose;Sergio D. Rosenzweig;Peter D. Burbelo

  • Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.

    Georgios Chamilos;Georgios Chamilos;Michail S Lionakis;Dimitrios P Kontoyiannis

  • Isolation, purification and labeling of mouse bone marrow neutrophils for functional studies and adoptive transfer experiments.

    Muthulekha Swamydas;Michail S. Lionakis

  • Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.

    Paul Bastard;Paul Bastard;Paul Bastard;Elizaveta Orlova;Leila Sozaeva;Romain Lévy;Romain Lévy

  • An Ocular Commensal Protects against Corneal Infection by Driving an Interleukin-17 Response from Mucosal γδ T Cells

    Anthony J. St. Leger;Jigar V. Desai;Rebecca A. Drummond;Abirami Kugadas

  • The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes

    Lydia Kasper;Annika König;Paul-Albert Koenig;Mark S. Gresnigt

  • Isolation of Mouse Neutrophils

    Unknown

  • CX3CR1-dependent renal macrophage survival promotes Candida control and host survival

    Michail S. Lionakis;Muthulekha Swamydas;Brett G. Fischer;Theo S. Plantinga

  • On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier.

    Nicolas Dutzan;Loreto Abusleme;Hayley Bridgeman;Teresa Greenwell-Wild

  • Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.

    Can Liu;Can Liu;Andrew J. Martins;William W. Lau;Nicholas Rachmaninoff;Nicholas Rachmaninoff

  • CARD9+ microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment

    Rebecca A. Drummond;Rebecca A. Drummond;Muthulekha Swamydas;Vasileios Oikonomou;Bing Zhai

Frequent Co-Authors

Dimitrios P. Kontoyiannis
Dimitrios P. Kontoyiannis The University of Texas MD Anderson Cancer Center
Russell E. Lewis
Russell E. Lewis University of Padua
Steven M. Holland
Steven M. Holland National Institute of Allergy and Infectious Diseases
Scott G. Filler
Scott G. Filler University of California, Los Angeles
Jean K. Lim
Jean K. Lim Icahn School of Medicine at Mount Sinai
Luigi D. Notarangelo
Luigi D. Notarangelo National Institutes of Health
Peter D. Burbelo
Peter D. Burbelo National Institutes of Health
Mark S. Anderson
Mark S. Anderson University of California, San Francisco
Alexandra F. Freeman
Alexandra F. Freeman National Institute of Allergy and Infectious Diseases
Stefania Pittaluga
Stefania Pittaluga National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology can open doors to diverse healthcare careers, including advanced nursing roles that blend immunology knowledge with patient care. Many professionals choose to enhance their qualifications by exploring specialized nursing programs. For those interested in mental health, the best psychiatric mental health nurse practitioner programs online offer strong clinical placement opportunities, crucial for building practical expertise alongside theoretical learning.

Cost is often a deciding factor for students, and finding affordable education options is key. The cheapest pmhnp programs online provide budget-friendly alternatives without compromising educational quality, making it easier for aspiring nurse practitioners to pursue their goals.

Advanced nursing degrees like the Doctor of Nursing Practice (DNP) are increasingly popular for career advancement. Salaries for DNP holders vary by region, but data on doctor of nursing practice salary highlights promising earning potential, reflecting the high demand for specialized healthcare providers.

For nurse practitioners considering specialization shifts, pathways such as transitioning from family nurse practitioner (FNP) to acute care are well-documented. Exploring fnp to acute care certification options can guide professionals aiming to broaden their scope of practice and meet evolving healthcare needs.

Best Scientists Citing Michail S. Lionakis

Trending Scientists

Recently Published Articles